Thank you
@Medfeb. I really appreciate this update.
To remind us all of
the timeline on this:
March 2020 - Cochrane was actively getting the author team together and said it anticipated the review would be completed in about 2 years from early 2020. That implies an expected completion date early 2022.
May 2021 new members of the IAG and review author team were announced.
June 2021 The author team is working on a first draft of the protocol for the review
No official updates since then.
So now in
October 2022 we are told unofficiallly that the draft protocol is nearly ready to be shared with the IAG. Presumaby that will lead to some revision before the public consultation.
I am speculating that this means the protocol won't be finalised until 2023.
And then the review itself will start. If the NICE review process is anything to go by, this could be a very length task, unless the review team have the good sense and permission from Cochrane to simply adopt the NICE detailed analysis of all the studies NICE included so they only have any studies NICE didn't include to analyse in detail.
Given the time it's taken just to get to a draft review, this looks like it could take years...
Edit to add. I don't blame the individuals on the review group. They are all busy professional people with other priorities too, and it can't be easy working at a distance rather than being able to get around a table and hammer things out.
This makes it all the more urgent that the current review be withdrawn immediately. If Cochrane is concerned that this leaves people with no review of exercise for ME/CFS, they can refer people to the NICE and CDC reviews and conclusions as useful alternatives.